Abselion announces £1.1m project to develop next-gen cell platform for viral vector production 21 Aug Written by Alexandra Collingbourne Alexandra Collingbourne Previous Previous VividQ opening US office after taking funding haul past $30m Next Next Hughes Hall honours Chausiaux as Heartfelt Technologies eyes global expansion
Abselion announces £1.1m project to develop next-gen cell platform for viral vector production 21 Aug Written by Alexandra Collingbourne Alexandra Collingbourne